Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 06/25/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCSPRNewsWire • 06/25/26
Doximity (DOCS) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 06/16/26
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/12/26
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law FirmPRNewsWire • 06/11/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCSGlobeNewsWire • 06/09/26
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?Zacks Investment Research • 05/28/26
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?The Motley Fool • 05/24/26
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based CareZacks Investment Research • 05/15/26
Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a TurnaroundZacks Investment Research • 05/15/26
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins DownZacks Investment Research • 05/14/26
Doximity, 'LinkedIn For Doctors,' Hits A Record Low On AI Growing PainsInvestors Business Daily • 05/14/26
Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care SettingsBusiness Wire • 05/13/26
Doximity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 05/13/26